Differentiating recurrent Guillain–Barre syndrome and acute-onset chronic inflammatory polyneuropathy: literature review
Acta Neurologica Belgica · 2024-10 · 124 (5) · 1467-1475
DOI: 10.1007/s13760-024-02557-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Neurologica Belgica, online erschienen am 25.04.2024. Verfasst von Berin Inan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculty of Medicine, Hacettepe University, Ankara, Turkey. berin.inan@yahoo.com. Hauptthemen laut MEDLINE: Guillain-Barre Syndrome, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Recurrence. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 78 Literaturangaben.
Abstract (Originalsprache)
Guillain-Barre syndrome (GBS) is an acute-onset immune-mediated polyneuropathy characterized by ascending symmetrical muscle weakness, diminished reflexes, and sensory symptoms. While GBS typically follows a monophasic course, some patients experience treatment-related fluctuations or recurrences, posing diagnostic challenges in distinguishing GBS from acute-onset chronic inflammatory polyneuropathy (A-CIDP). A-CIDP, may present acutely, simulating GBS, with a nadir in less than 8 weeks, subsequently evolving into a chronic or relapsing course. The distinction between recurrent GBS and A-CIDP is crucial, as A-CIDP necessitates long-term immunosuppression. A PubMed search was conducted using the search terms 'recurrent Guillain Barre syndrome' and 'acute onset CIDP' focusing on studies in the English language, published between January 1, 2004 and April 30, 2023. Overlapping clinical features, particularly in the early stages, complicate differentiation between recurrent GBS and CIDP. Electrophysiological studies, ultrasonography, and immunological markers have been explored for discrimination; however, definitive criteria for differentiation remain elusive. Recent follow-up studies have further blurred the boundaries between recurrent GBS and A-CIDP, suggesting the persistence of underlying immune processes even in GBS patients without clinical deterioration. This emphasizes the necessity of reevaluating diagnostic criteria and treatment strategies. In conclusion, distinguishing recurrent GBS from A-CIDP remains an ongoing challenge. Existing evidence questions the categorization of recurrent GBS as a distinct entity, challenging its very existence. Continued research is necessary to refine diagnostic criteria and deepen our understanding of these conditions, ultimately advancing patient care. This review delves into the intricacies of recurrent GBS and A-CIDP differentiation and highlights the need for a reevaluation of the recurrent GBS concept.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Faculty of Medicine, Hacettepe University, Ankara, Turkey. berin.inan@yahoo.com.
- Department of Neurology, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey. berin.inan@yahoo.com.
- Department of Neurology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
- Private Neurology Practice, Ankara, Turkey.
Zitieren
APA
Inan, B., Bekircan-Kurt, C. E., Demirci, M., Erdem-Ozdamar, S., & Tan, E. (2024). Differentiating recurrent Guillain–Barre syndrome and acute-onset chronic inflammatory polyneuropathy: literature review. Acta Neurologica Belgica, 124(5), 1467-1475. https://doi.org/10.1007/s13760-024-02557-2
Vancouver
Inan B, Bekircan-Kurt CE, Demirci M, Erdem-Ozdamar S, Tan E. Differentiating recurrent Guillain–Barre syndrome and acute-onset chronic inflammatory polyneuropathy: literature review. Acta Neurologica Belgica. 2024;124(5):1467-1475. doi:10.1007/s13760-024-02557-2
BibTeX
@article{Inan2024,
author = {Inan, Berin and Bekircan-Kurt, Can Ebru and Demirci, Mehmet and Erdem-Ozdamar, Sevim and Tan, Ersin},
title = {Differentiating recurrent Guillain–Barre syndrome and acute-onset chronic inflammatory polyneuropathy: literature review},
journal = {Acta Neurologica Belgica},
year = {2024},
volume = {124},
number = {5},
pages = {1467--1475},
doi = {10.1007/s13760-024-02557-2}
}
EUVIMED